D
uring the past several decades, stroke care delivery has transformed from experience-based to evidence-based practice. The rapid development of thrombolysis, endovascular therapy, and secondary prevention treatment has led to an increase in the number of clinical research studies and thus, an increased need for multicenter clinical trials. Although clinical trials with multiple sites are labor intensive, they are necessary for studying large samples of patients to determine what therapeutic, preventative, and diagnostic products or interventions are best across multiple settings and will be effective in actual practice. In addition to the scientific contribution of multicenter trials, they also help build capacity for research at individual centers. Each participating site needs a local principal investigator (PI), creating an exciting leadership opportunity for early career stroke physicians and researchers. This article will focus on the opportunities, advantages, challenges, and potential pitfalls of becoming a local PI for a large multicenter clinical trial.
Opportunities for Stroke Physicians and Researchers
Clinical research, especially multicenter randomized controlled trials, is the cornerstone of evidence-based medical practice. Rigorous and well-conducted clinical trials are the foundation of scientific knowledge for guidelines that shape clinical practice of acute stroke management and secondary prevention. 1 A site PI is defined as a person who is responsible for trial selection, site activation, and study conduct in a local site to maximize enrollment, optimize data quality, and ensure patient retention. Site PIs play an important role in the development of evidence. Serving as site PI involves leading discussions for which trials to participate in, developing or implementing a strategy to maximize enrollment, reinforcing data quality and ensuring patient retention, and providing regulatory, financial, and scientific oversight. Becoming an early career site PI brings a level of responsibility and recognition beyond every day clinical practice. Stroke physicians may choose research that combines their area of clinical practice, scientific curiosity, and interests of their mentors or institution. In doing so, the site PI expands his or her local network and has more opportunities to become involved in a larger umbrella of research in the stroke scientific community.
Advantages of Serving as a Site PI
Physician-scientists devote themselves, through research, to expanding the knowledge base for evidence-based treatment and preventive approaches, thereby expediting the interactive transformation of research ideas to clinical practice. Serving as site PI for a multicenter clinical trial has several advantages for early career professional development. First, learning clinical trial design and methodology from the perspective of a site PI is an experiential form of research training. This opportunity to learn the specifics of study protocols, ethics, patient selection, efficacy and safety end points, adverse events, data management, quality and utilization, and dissemination all contribute to the expansion of knowledge and skills for future clinical research. Second, clinical research provides early career stroke physicians with an opportunity to stay current with cuttingedge therapeutic strategies and gain experience in working with drugs, devices, and interventions not yet approved by the regulatory agencies. For example, site PIs who recruited patients who had last been known to be well 6 to 24 hours earlier and had a mismatch between clinical deficit and infarct to participate in the DAWN trial (Diffusion-Weighted Imaging or Computerized Tomography Perfusion Assessment With Clinical Mismatch in the Triage of Wake-Up and Late Presenting Strokes Undergoing Neurointervention With Trevo), 2 saw firsthand the benefits of late-window thrombectomy for carefully selected patients. Stroke physicians who joined this trial as site PI may have a better understanding of the method of image reading and criteria for endovascular treatment to then implement in clinical practice after the findings of the DAWN trial were integrated into clinical guidelines. These experiences as an early career site PI have a third advantage: being part of network of PIs. This network may serve as a peer group for idea exchange for future research or leaders who can help accelerate research findings into practice by mentoring others with implementation, particularly at sites that were not a part of the trial.
Other professional advantages of serving as a site PI include the opportunity to be a coauthor on publications, participate or lead secondary data analyses after the main findings are published, and propose ancillary studies. Participation in a trial as a clinical site investigator is a favorable factor when submitting an application for an ancillary study. The National Institute of Neurological Disorders and Stroke invites investigator-initiated research project applications for ancillary studies of ongoing large-scale clinical trials, epidemiological studies, and disease databases. These advantages of participation are important for career advancement and scholarship advancement.
Challenges and Pitfalls to Serving as a Clinical Trial Site PI
Although serving as a site PI affords opportunities for leadership, scholarship, and partnership development, a variety of challenges may surface before or during the experience. These challenges may occur at the organizational or individual levels and include a lack of time, resources, rewards, and recognition. 3 Receiving an invitation to serve as site PI can create conflicts between the role of clinician and scientist. The many years of clinical training will not be matched with years in research training, and an early career physician may not be prepared to advocate for the necessary support, time, and resources to be efficient and effective as a site PI. This can result in challenges with study start-up, staffing for daily operations and regulatory oversight, data quality, and reporting delays.
Serving as site PI requires a commitment of additional time and effort not always reflected in reimbursement and recognition policies. It takes a physician on average 4 hours of work for every patient enrolled in a trial. 4 Some of that time is allocated to patients who ultimately fail to join the clinical trial. When a patient enrolls in a trial, additional time is needed for data collection, documentation requirements, and depending on the protocol, follow-up visits that go beyond expectations of clinical practice. These activities can add significant time and effort to a physician's workload. In some academic institutes, clinical trial involvement is not well rewarded in tenure and promotion processes and misaligned with the time investment required for site leadership in a large, multi-institutional trial. These are important considerations and discussions to be had before accepting the role. There are several ways to mitigate these issues. Early career site PIs should consider having an experienced mentor and meeting regularly with that person and getting buy-in and support from the research department leadership before committing to the trial.
An early career site PI may not be fully aware of the institution's readiness to participate in a multicenter clinical trial. Without prior trial experience or research experience at the institution, early career physicians can excitedly accept the role and quickly become overwhelmed with demands they are not prepared to meet. Enrolling an adequate number of eligible patients is still a huge challenge, particularly in acute stroke trials. A systematic review demonstrated that neither recruitment rate nor efficiency has increased in acute stroke trials for the past 25 years. 5 Acute stroke trials with a 6-hour treatment window had approximately half the recruitment rate of trials that used a treatment window >6 hours. 6 In addition, with a greater number of community hospitals able to treat patients with acute stroke, they may be reluctant to transfer acute stroke patients to academic institutions. It is essential that a site PI understands the factors that may detract or bolster patient recruitment to accurately assess the benefits and challenges to serving as an individual site. This may include assessment of the patient population at the investigator's institution and the factors that may affect clinical trial recruitment, such as health literacy, cultural barriers, and socioeconomic status. This assessment can be challenging as an early career physician but crucial to the success of a site for a multicenter clinical trial expected to enroll the calculated sample size within a stipulated period.
Infrastructure to Support Clinical Trial Involvement
There are common components that provide the framework for a sustainable and continuous clinical trials infrastructure: trained clinical trial personnel, protocol development support, regulatory approval, patient recruitment and data collection plans, ethical review, participant protections, adverse event reporting, and so on. Early career stroke physicians can seek help from the clinical trial coordinating center for any of these components. This becomes especially important when clinical trial participation provides financial, equipment, or personnel resources that may require additional local coordination. For example, participating in clinical trials networks like the National Institutes of Health StrokeNet, a network of >25 regional coordinating centers and >200 hospitals, offers a centralized institutional review board, streamlined contracting, mentorship, and training to maximize efficiencies to develop, promote, and conduct stroke clinical trials in stroke prevention, treatment, and recovery. Sustainable finances, including starting funds, funding per patient, and its relationship with the resources used by the site PI, are also ensured when the trials are implemented at local institutions. Acute stroke diagnosis, treatment, recovery, and secondary prevention involve multidisciplinary cooperation. The DAWN trial, for example, required specific computed tomography software to assist with recruitment. Assigning coinvestigators from emergency or neuroradiology departments could be a strategic approach to patient enrollment for acute stroke trials. Therefore, an important role of a site PI is to establish a multidisciplinary group that can coordinate trial implementation.
Conclusions
The growing number and complexity of stroke clinical trials provide early career stroke physicians with opportunities for leadership, scholarship, and partnership as site PI for multicenter clinical trials. Site PIs can obtain professional development and recognition and may also face challenges related to lack of time, experience, and resources. Open communication and mentoring, locally and as part of the clinical trials infrastructure, should be developed for early career site PIs to succeed in their important role in the advancement of clinical stroke research.
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